These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2828521)

  • 1. Virus excretion and strain specific antibody responses after oral poliovaccine in previously immunised children.
    Roivainen M; Thodén CJ; Stenvik M; Pöyry T; Hovi T
    J Med Virol; 1987 Nov; 23(3):249-56. PubMed ID: 2828521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response to oral poliovaccine in persons aged 16-18 years.
    Smith JW; Lee JA; Fletcher WB; Morris CA; Parker DA; Yetts R; Magrathe DI; Perkins FT
    J Hyg (Lond); 1976 Apr; 76(2):235-47. PubMed ID: 177700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines.
    Ramsay ME; Begg NT; Gandhi J; Brown D
    Pediatr Infect Dis J; 1994 Dec; 13(12):1117-21. PubMed ID: 7892081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population.
    Hovi T; Cantell K; Huovilainen A; Kinnunen E; Kuronen T; Lapinleimu K; Pöyry T; Roivainen M; Salama N; Stenvik M
    Lancet; 1986 Jun; 1(8495):1427-32. PubMed ID: 2872526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.
    Slater PE; Orenstein WA; Morag A; Avni A; Handsher R; Green MS; Costin C; Yarrow A; Rishpon S; Havkin O
    Lancet; 1990 May; 335(8699):1192-5; discussion 1196-8. PubMed ID: 1971043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of live attenuated polioviruses in the faeces of orally vaccinated children. Comparison of two immunization schedules.
    Kucharská Z
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(2):211-8. PubMed ID: 2991368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.
    Green MS; Handsher R; Cohen D; Melnick JL; Slepon R; Mendelsohn E; Danon YL
    Vaccine; 1993; 11(1):75-81. PubMed ID: 8381249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antibody responses and virus shedding following administration of trivalent oral poliomyelitis vaccines prepared either in monkey or human diploid cell substrates.
    Freestone DS; Kelly A; Ferris R; Simmons RL; Bowker C; Letley E; Bye C
    J Hyg (Lond); 1980 Feb; 84(1):17-28. PubMed ID: 6243327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland.
    Pöyry T; Stenvik M; Hovi T
    Appl Environ Microbiol; 1988 Feb; 54(2):371-4. PubMed ID: 2833160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excretion of attenuated polioviruses in children vaccinated with live oral poliovirus vaccine.
    Kucharská Z; Srámová H; Zdrazílek J
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):74-82. PubMed ID: 6282962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliovaccine virus in the cerebrospinal fluid after oral polio vaccination.
    Rantala H; Uhari M; Tuokko H; Stenvik M; Kinnunen L
    J Infect; 1989 Sep; 19(2):173-6. PubMed ID: 2553821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies to polioviruses & enteroviruses excreted by healthy children in Bombay.
    Deshpande JM; Kamat JR; Rao VK; Nadkarni SS; Kher AS; Salgaokar SD; Rodrigues JJ
    Indian J Med Res; 1995 Feb; 101():50-4. PubMed ID: 7729847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee.
    Minor PD; John A; Ferguson M; Icenogle JP
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():693-706. PubMed ID: 2420925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-year follow-up of the immune status of young adults given a single booster dose of trivalent oral poliovaccine.
    Green MS; Handsher R; Slepon R; Ashkenazi S; Mendelson E; Cohen D
    Vaccine; 1994 May; 12(7):582-4. PubMed ID: 8085373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources.
    Dunn G; Begg NT; Cammack N; Minor PD
    J Med Virol; 1990 Oct; 32(2):92-5. PubMed ID: 2177777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadequacy of mucosal IgM antibodies in selective IgA deficiency: excretion of attenuated polio viruses is prolonged.
    Savilahti E; Klemola T; Carlsson B; Mellander L; Stenvik M; Hovi T
    J Clin Immunol; 1988 Mar; 8(2):89-94. PubMed ID: 2836474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term excretion of vaccine-derived poliovirus by a healthy child.
    Martín J; Odoom K; Tuite G; Dunn G; Hopewell N; Cooper G; Fitzharris C; Butler K; Hall WW; Minor PD
    J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.